Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × Squamous Cell Carcinoma of Head and Neck × Clear all

Squamous Cell Carcinoma of Head and Neck

NCT06273852 2025-08-11

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Phase EARLY_PHASE1 Completed

8 enrolled

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT03618654 2025-05-15

Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma

Phase EARLY_PHASE1 Completed

38 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04883645 2025-01-28

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

Phase EARLY_PHASE1 Completed

16 enrolled 10 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03459729 2025-01-16

Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer

Phase EARLY_PHASE1 Completed

6 enrolled 14 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06413095 2024-05-14

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

Phase EARLY_PHASE1 Completed

13 enrolled

Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Sarcoma

NCT03868020 2024-03-28

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Phase EARLY_PHASE1 Completed

16 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06062602 2023-10-06

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

Phase EARLY_PHASE1 Completed

15 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03575598 2023-07-27

SNOW

Phase EARLY_PHASE1 Completed

10 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04065555 2022-07-29

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Phase EARLY_PHASE1 Completed

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03182959 2021-06-21

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

Phase EARLY_PHASE1 Completed

6 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Head and Neck Neoplasms, Hyperplasia

NCT02794675 2020-12-23

Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer

Phase EARLY_PHASE1 Completed

15 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03923998 2019-04-23

Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers

Phase EARLY_PHASE1 Completed

8 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT00601913 2018-07-05

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Phase EARLY_PHASE1 Completed

24 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02608736 2018-02-01

GAMA

Phase EARLY_PHASE1 Completed

42 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Phase EARLY_PHASE1 Completed

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01275183 2015-06-18

Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck

Phase EARLY_PHASE1 Completed

5 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Clinical Trials

Using MASL to Combat Oral Cancer

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

SNOW

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer

Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

GAMA

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck